The skin care and treatment market in China, in terms of revenue, is expected to grow by 9.9 percent annually through 2029, according to the latest estimates. Skin care is essential for maintaining skin health and preventing skin conditions. It helps to protect the skin from environmental factors, such as…
Global Nanomaterials in Personalized Medicine Market
The global nanomaterials in personalized medicine market size is projected to grow by USD 229 billion from 2022 to 2028, registering a CAGR of 9.8 percent, according to a new report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on nanomaterials in personalized medicine can be segmented by product: gold nanoparticles, liposomes, monoclonal antibodies, nanocrystals, proteins, quantum dots. The proteins segment is estimated to account for the largest share of the global nanomaterials in personalized medicine market. Nanomaterials in personalized medicine market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW).
The global nanomaterials in personalized medicine market is highly competitive. The prominent players operating in the global nanomaterials in personalized medicine market include Abraxis BioScience Inc., Bristol-Myers Squibb Company (BMS), Camurus AB, Eisai Co. Ltd., Johnson & Johnson, Merck & Co. Inc., NanoCarrier Co. Ltd., Novartis AG.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the Global Nanomaterials in Personalized Medicine Market
– Identify segments/areas to invest in over the forecast period in the Global Nanomaterials in Personalized Medicine Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
Global Nanomaterials in Personalized Medicine Market - Report Scope
Abraxis BioScience Inc., Bristol-Myers Squibb Company (BMS), Camurus AB, Eisai Co. Ltd., Johnson & Johnson, Merck & Co. Inc., NanoCarrier Co. Ltd., Novartis AG
According to the latest research, the skin-related beauty market in China is estimated to increase at the rate of 10.1% each year in the period from 2023 to 2029. Skin-related beauty refers to the products and treatments aimed at improving the health, appearance, and overall condition of the skin. It…